Cargando…
Retargeted Clostridial Neurotoxins as Novel Agents for Treating Chronic Diseases
[Image: see text] Botulinum neurotoxin (BoNT) A and B are used to treat neuropathic disorders; if retargeted, these agents could be used to treat medical conditions that involve secretion from nonneuronal cells. Here, we report novel strategies for successfully retargeting BoNTs, and also tetanus ne...
Autores principales: | Yeh, Felix L., Zhu, Yiming, Tepp, William H., Johnson, Eric A., Bertics, Paul J., Chapman, Edwin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2011
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226321/ https://www.ncbi.nlm.nih.gov/pubmed/22047069 http://dx.doi.org/10.1021/bi201490t |
Ejemplares similares
-
Advances in Clostridial and Related Neurotoxins
por: Pellett, Sabine
Publicado: (2022) -
SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
por: Yeh, Felix L., et al.
Publicado: (2010) -
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons
por: Dong, Min, et al.
Publicado: (2007) -
Botulinum neurotoxin–encoding plasmids can be conjugatively transferred to diverse clostridial strains
por: Nawrocki, Erin M., et al.
Publicado: (2018) -
Resolving the Molecular Steps in Clostridial Neurotoxin Light Chain Translocation
por: Zuverink, Madison, et al.
Publicado: (2020)